Corticosteroid-resistant Sweet's syndrome as the first manifestation of myelodysplastic/ myeloproliferative neoplasm-unclassifiable: a case report. Issue 4 (20th September 2022)

• Record Type: Journal Article
• Authors: Pan, Lina; Zhang, Jingru; Li, Peng; Zhao, Chuanli; Zang, Shaolei; Ji, Min; Lu, Fei; Ye, Jingjing; Zhang, Chunqing; Ji, Chunyan
• Is Part Of: Emergency and critical care medicine. Volume 2:Issue 4(2022)
• Page Start: 233
• Page End: 238
• Publication Date: 2022-09-20
• Subjects: Case report -- Corticosteroid-resistant -- Intravenous immunoglobulin -- Myelodysplastic/myeloproliferative neoplasm-unclassifiable -- Sweet's syndrome; Emergency medicine -- Periodicals; Critical care medicine -- Periodicals; Critical care medicine; Emergency medicine; Periodicals; 616.025
• DOI: 10.1097/EC9.0000000000000034
• Languages: English
• ISSNs: 2097-0617

Abstract

Abstract: A middle-aged man was diagnosed with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U), with severe and extensive corticosteroid-resistant Sweet's syndrome (SS) as the first manifestation, with evidence of clinical manifestations, pathological description, and laboratory evaluation. The skin lesions continued to spread despite treatment with systemic corticosteroids but were successfully treated with intravenous immunoglobulin (IVIG).